Provided by Tiger Fintech (Singapore) Pte. Ltd.

GlaxoSmithKline PLC

39.41
+0.75001.94%
Volume:1.89M
Turnover:74.46M
Market Cap:79.95B
PE:20.04
High:39.65
Open:39.54
Low:39.31
Close:38.66
Loading ...
Mar 18, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 13, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 11, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 09, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 09, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 06, 2020

Annual Report

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 04, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 02, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 28, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 27, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 21, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 20, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 20, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 20, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 19, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 19, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 19, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 19, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 19, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 18, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership